CAPRICOR THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
CAPRICOR THERAPEUTICS, INC. (CAPR) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $2.17 thousand as of 2020-12-31, per its 10-K filed 2021-03-15.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2021-03-15
- 2020-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.17K.
- 2020-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.17K.
- 2020-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.17K.
- 2020-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $3.25K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2020-12-31 | $2.17K 10-K · filed 2021-03-15 |
| 2020-09-30 | $2.17K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.17K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.25K 10-Q · filed 2020-05-15 |
| 2019-09-30 | $10.82K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $21.64K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $32.46K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $43.28K 10-K · filed 2019-03-29 |
| 2018-09-30 | $10.82K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $21.64K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $32.46K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $43.28K 10-K · filed 2018-03-22 |
| 2017-09-30 | $12.19K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $24.38K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $36.56K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $48.75K 10-K · filed 2017-03-16 |
| 2015-12-31 | $48.75K 10-K · filed 2016-03-30 |
| 2015-09-30 | $12.19K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $24.38K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $49.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $49.00K 10-K · filed 2015-03-16 |
| 2013-12-31 | $4.33K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |